Lymphocytes from B-acute lymphoblastic leukemia patients present differential regulation of the adenosinergic axis depending on risk stratification

PURPOSE: Although risk-stratified chemotherapy regimens improve B-cell acute lymphoblastic leukemia (B-ALL) clinical outcome, relapse occurs in a significant number of cases. The identification of new therapeutic targets as well as prognostic and diagnostic biomarkers can improve B-ALL patients'...

Descripción completa

Detalles Bibliográficos
Autores principales: Brum da Silva Nunes, Vitória, Kehl Dias, Camila, Nathali Scholl, Juliete, Nedel Sant’Ana, Alexia, de Fraga Dias, Amanda, Granero Farias, Mariela, Alegretti, Ana Paula, Sosnoski, Monalisa, Esteves Daudt, Liane, Bohns Michalowski, Mariana, Oliveira Battastini, Ana Maria, Paz, Alessandra Aparecida, Figueiró, Fabrício
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800668/
https://www.ncbi.nlm.nih.gov/pubmed/36581667
http://dx.doi.org/10.1007/s12672-022-00602-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800668/
https://www.ncbi.nlm.nih.gov/pubmed/36581667
http://dx.doi.org/10.1007/s12672-022-00602-1

Ejemplares similares